Zoobia W. Chaudhry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zoobia W. Chaudhry has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Kimberly A. Gudzune
Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publications Selvi Rajagopal
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 shared publicationsA. K. Mehta
The Johns Hopkins Bayview Medical Center, Baltimore, MD, USA
1 shared publication- Adham Khalil
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, United States
1 shared publication - Alan J. Kim
Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 1800 Orleans St, 7203 Sheikh Zayed Tower, Ste 7, Baltimore, MD 21287
1 shared publication Bill Morefield
Division of Vascular and Interventional Radiology, Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
1 shared publication
Latest Publications
- Open Access
- 25 September 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100211
Establishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience
- 25 September 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100211
Open AccessEstablishing a multidisciplinary bariatric arterial embolization program: A two-year clinical experience
- Open Access
- 27 August 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100204
Developing and implementing an obesity medicine fellowship program: Experience at a U.S. academic medical center
- 27 August 2025
- Published by Elsevier in Obesity Pillars
- Vol. 16, 100204
Open AccessDeveloping and implementing an obesity medicine fellowship program: Experience at a U.S. academic medical center
- Open Access
- 2 January 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (1) , 77-78
Health Care Workers and War in the Middle East
To the Editor We write to respond to a recent Viewpoint, taking issue with its substantial omissions regarding the humanitarian crisis and war crimes occurring
- 2 January 2024
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (1) , 77-78
Open AccessHealth Care Workers and War in the Middle East
To the Editor We write to respond to a recent Viewpoint, taking issue with its substantial omissions regarding the humanitarian crisis and war crimes occurring
- 26 May 2016
- Published by Wiley in Obesity Reviews
- Vol. 17 (8) , 758-769
A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus
Summary: Objective: We examined the glycemic benefits of commercial weight loss programmes as compared with control/education or counselling among overweight and obese adults with and without type 2 diabetes mellitus (T2DM).Methods: We searched MEDLINE, Cochrane Database of Systematic Reviews, and references cited by individual programmes. We included randomized controlled trials of ≥12 weeks duration. Two reviewers extracted information on study design, population characteristics, interventions, and mean changes in haemoglobin A1c and glucose.Results: We included 18 randomized controlled trials. Few trials occurred among individuals with T2DM. In this population, Jenny Craig reduced A1c at least 0.4% more than counselling at 12 months, Nutrisystem significantly reduced A1c 0.3% more than counselling at 6 months, and OPTIFAST reduced A1c 0.3% more than counselling at 6 months. Among individuals without T2DM, few studies evaluated glycemic outcomes, and when reported, most did not show substantial reductions.Discussion: Few trials have examined whether commercial weight loss programmes result in glycemic benefits for their participants, particularly among overweight and obese individuals without T2DM. Jenny Craig, Nutrisystem and OPTIFAST show promising glycemic lowering benefits for patients with T2DM, although additional studies are needed to confirm these conclusions. © 2016 World Obesity
- 26 May 2016
- Published by Wiley in Obesity Reviews
- Vol. 17 (8) , 758-769
A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus
Summary: Objective: We examined the glycemic benefits of commercial weight loss programmes as compared with control/education or counselling among overweight and obese adults with and without type 2 diabetes mellitus (T2DM).Methods: We searched MEDLINE, Cochrane Database of Systematic Reviews, and references cited by individual programmes. We included randomized controlled trials of ≥12 weeks duration. Two reviewers extracted information on study design, population characteristics, interventions, and mean changes in haemoglobin A1c and glucose.Results: We included 18 randomized controlled trials. Few trials occurred among individuals with T2DM. In this population, Jenny Craig reduced A1c at least 0.4% more than counselling at 12 months, Nutrisystem significantly reduced A1c 0.3% more than counselling at 6 months, and OPTIFAST reduced A1c 0.3% more than counselling at 6 months. Among individuals without T2DM, few studies evaluated glycemic outcomes, and when reported, most did not show substantial reductions.Discussion: Few trials have examined whether commercial weight loss programmes result in glycemic benefits for their participants, particularly among overweight and obese individuals without T2DM. Jenny Craig, Nutrisystem and OPTIFAST show promising glycemic lowering benefits for patients with T2DM, although additional studies are needed to confirm these conclusions. © 2016 World Obesity
- Open Access
- 26 June 2013
- Published by Springer Nature in SpringerPlus
- Vol. 2 (1) , 277
Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review
- 26 June 2013
- Published by Springer Nature in SpringerPlus
- Vol. 2 (1) , 277
Open AccessComparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review